BWLSA
GRAL

Blue Water Life Science Advisors’s GRAIL Inc GRAL Stock Holding History

Blue Water Life Science Advisors’s Portfolio GRAL Stock Details GRAL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-99,000
Closed -$8.47M – 11
2025
Q4 		$8.47M Buy
+99,000
New +$8.55M 5.32% 8

Other funds holding GRAL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
APCM
Arbiter Partners Capital Management New York $197M AUM 47.99% 1-Year Est. Return

Blue Water Life Science Advisors's GRAL Position: Q1 2026 in Review

Blue Water Life Science Advisors sold out of GRAIL Inc (GRAL) in Q1 2026, closing a stake of 99,000 shares — an estimated $8.47M sold.

Blue Water Life Science Advisors first reported a position in GRAL in Q4 2025 and held it in 1 quarter. The position peaked at $8.47M in Q4 2025. 366 funds tracked by Wall St. Rank hold GRAL as of Q1 2026.

  • Blue Water Life Science Advisors reported no remaining GRAIL Inc position as of Q1 2026 after selling out during the quarter.
  • Blue Water Life Science Advisors sold 99,000 GRAIL Inc shares in Q1 2026, an estimated $8.47M.
  • Blue Water Life Science Advisors first reported a position in GRAIL Inc in Q4 2025 and held it in 1 quarter.
  • Blue Water Life Science Advisors's GRAIL Inc position peaked at $8.47M in Q4 2025.
  • 366 funds tracked by Wall St. Rank held GRAIL Inc as of Q1 2026.

Based on Blue Water Life Science Advisors's 13F filing for Q1 2026, filed 14 May 2026.